Contractile effects of tacrolimus in human and rat isolated renal arteries

Journal of Autonomic Pharmacology

Volumn 21, Issue 4, 2001, Pages 205-210

  Schwertfeger, E ^a   Wehrens, J ^a   Oberhauser, V ^a   Katzenwadel, A ^a   Rump, L C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; NEUROTRANSMITTER; NORADRENALIN; TACROLIMUS;

ADULT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRESSOR RESPONSE; RAT; RENAL ARTERY; SPECIES COMPARISON;

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; RATS; RATS, WISTAR; RENAL ARTERY; TACROLIMUS; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0035740548     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.2001.00228.x     Document Type: Article

References (22)

1. Cyclosporine to tacrolimus: Effect on hypertension and lipid profiles in renal allografts
2. Hypertension following kidney transplantation
3. Effects of FK506 in rat and human resistance arteries
4. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus
5. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interactions with vascular smooth muscle
6. Cyclosporine and oxidized lipoproteins affect vascular reactivity. Influence of the endothelium
7. FK 506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS)
8. Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling
9. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group
10. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects
11. Endothelial dysfunction: From physiology to therapy
12. Effect of cyclosporine administration on renal hemodynamics in conscious rats
13. Neuropeptide Y and ATP interact to control renovascular resistance in the rat
14. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation
15. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506
16. Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms
17. ABC-Technik
18. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation
19. Conversion from cyclosporine A to tacrolimus in renal transplants: Pharmacokinetic profile and influence on renal vascular resistance
20. Mechanisms of FK 506-induced hypertension in the rat
21. Cyclosporine-induced hypertension after transplantation
22. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings